Form 4: Elanco Animal Health Executive Shiv O'Neill Reports Stock Transactions
SEC Form 4 Filing
Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, reports the acquisition and disposal of common stock on February 19, 2025.
Summary
- On February 19, 2025, Shiv O'Neill, GC AND CORP SEC of Elanco Animal Health Inc, acquired 6,019 shares of common stock at $0.
- On the same day, O'Neill disposed of 2,943 shares of common stock at $11.24.
- Following these transactions, O'Neill directly owns 26,849 shares of Elanco Animal Health Inc.
- O'Neill has a power of attorney naming Todd S. Young, Megan Y. Brady, Amy C. Seidel, and Amra Hoso as attorneys-in-fact to handle securities filings.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting stock transactions, which carries a neutral sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is standard practice in publicly traded companies to ensure transparency and compliance with securities regulations.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
Key Dates
| Date | Description |
|---|---|
| May 14, 2024 | Date of the Power of Attorney. |
| February 19, 2025 | Date of stock acquisition and disposal. |
| February 21, 2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Elanco Animal Health Inc, Shiv O'Neill, stock transaction, beneficial ownership, securities, power of attorney
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.